— Know what they know.
Not Investment Advice

GSRX OTC

GSRX Industries Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -0.0% 5Y: -99.7%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 51 · $8180 mcap · 11M float · 0.065% daily turnover

Cash Flow Trends

Operating Cash Flow
-$2M +62.3% ▲
Capital Expenditures
$566K +87.0% ▲
Free Cash Flow
-$3M +72.8% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$709K +87.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2015FY2016FY2017FY2018FY2019
— Operating Activities —
Net Income-$83K-$88K-$26M-$17M-$37M
Depreciation & Amort.$0$0$0$108K$406K
Stock-Based Comp.$0$0$0$11K$19K
Change in Working Capital$27K$26K$195K-$414K$625K
Other Non-Cash Items$0$0$25M$11M$34M
Operating Cash Flow-$56K-$62K-$1M-$6M-$2M
— Investing Activities —
Capital Expenditures$0$0-$242K-$3M-$431K
Acquisitions (Net)$0$0$0$0-$250K
Investment Purchases$0$0$0$0-$70K
Investment Sales$0$0$0$0$0
Other Investing$0$0-$503K-$2M-$445K
Investing Cash Flow$0$0-$745K-$5M-$1M
— Financing Activities —
Net Debt Issuance$56K$62K$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$234K$351K$2M
Financing Cash Flow$56K$62K$9M$5M$3M
Net Change in Cash$0$0$7M-$5M-$709K
Cash End of Period$0$0$7M$1M$604K
Free Cash Flow-$56K-$62K-$2M-$10M-$3M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms